Skip to main content
Toggle navigation
Search
Home
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
P
Paiva, Bruno
Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain
Abstract Introduction
Location: Hall FG
Bruno Paiva
Abstract Session 8
Location: Room 718
Bruno Paiva
(OA-32) Idecabtagene Vicleucel (ide-cel) and Endogenous Immune Profiles Linked to Progression-Free Survival in Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Location: Room 718
Bruno Paiva
(OA-42) Clonotypic B Cells are Passengers During Malignant Transformation and not Drivers of Disease Progression in Plasma Cell (PC) Neoplasms
Location: Room 718
Bruno Paiva
Parekh, Samir
Mount Sinai Medical Center, New York, NY, USA
Role of immune system as mechanism of resistance to T-cell engagers
Location: Hall FG
Samir Parekh
Patel, Krina
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
Improving patient care: lessons from real-world evidence
Location: Hall FG
Krina Patel
(PA-145) Treatment-Free Hospitalization-Free Time With CAR T-Cell Therapy Versus Standard Regimens and Quality of Life Implications in Patients With Relapsed/Refractory MM: Findings From the KarMMa-3 Trial
Location: Room 714A
Krina Patel
Pawlyn, Charlotte
The Institute of Cancer Research and The Royal Marsden Hospital
Core Session 4: Relapse within 1-3 lines of therapy
Location: Hall FG
Charlotte Pawlyn
Perrot, Aurore
University of Toulouse, University Hospital Department of Hematology, IUCT Oncopole CRCT, Toulouse, France
Age or fitness - who should get a transplant?
Location: Hall FG
Aurore Perrot
Pfeffer, Kirsten
Mayo Clinic
(PA-084) Drivers of Primary Resistance to BCMA-targeted T Cell Redirected Therapies in High Tumor Burden
Location: Room 714A
Kirsten Pfeffer
Pilcher, William
Emory University
(PA-255) Multi-hit Cytogenetics Risk Events Associated with IFN-I Suppression across TME of NDMM Patients and Poor Outcomes
Location: Room 714A
William Pilcher
Popat, Rakesh
NIHR UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, UK
Round Table discussion
Location: Hall FG
Rakesh Popat
Puig, Noemi
Hospital Universitario de Salamanca, Instituto de investigación biomédica de Salamanca (IBSAL)
Meet the Experts: MRD in clinical practice
Location: Room 714B
Noemi Puig
Puliafito, Benjamin
Massachusetts General Hospital
(OA-12) First-in-Human Phase 1 Trial of Trimeric APRIL (TriPRIL) CAR-T Cells in Relapsed or Refractory Multiple Myeloma
Location: Room 701
Benjamin Puliafito
Toxicity management, infection management, secondary cancers and delayed neurotoxicity
Location: Hall FG
Benjamin Puliafito
